Open the Floodgates: The Potential Impact on Litigation Against FDA if the Supreme Court Reverses or Curtails Chevron Deference

被引：0

作者：

Landmon, Chad ^{[1
,2
]}

Alfano, Alexander ^{[3
]}

Divelbiss, Michelle ^{[3
]}

机构：

[1] Axinn Veltrop & Harkrider LLP, Firms FDA Grp, New York, NY 10036 USA

[2] Axinn Veltrop & Harkrider LLP, Intellectual Property Practice Grps, New York, NY 10036 USA

[3] Axinn, New York, NY USA

来源：

FOOD AND DRUG LAW JOURNAL | 2019年 / 74卷 / 03期

关键词：

AGENCY INTERPRETATIONS; JUDICIAL DEFERENCE;

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

The Supreme Court is drastically shifting, and several Supreme Court precedents may get a fresh look. The focus of this paper is on Chevron deference and what it could mean for FDA-regulated companies if FDA no longer has this powerful weapon in its arsenal. This paper is not an argument for or against Chevron deference, but simply provides an analysis of how certain cases could have turned out and what the future may look like with an even playing field.

引用

页码：358 / 378

页数：21